4,582
Views
42
CrossRef citations to date
0
Altmetric
Research Paper

Pertussis

Current perspectives on epidemiology and prevention

, , , , , & show all
Pages 108-117 | Received 06 Aug 2014, Accepted 06 Aug 2014, Published online: 01 Nov 2014

References

  • Hewlett EL, Burns DL, Cotter PA, Harvill ET, Merkel TJ, Quinn CP, Stibitz ES. Pertussis pathogenesis--what we know and what we don’t know. J Infect Dis 2014; 209:982 - 5; http://dx.doi.org/10.1093/infdis/jit639; PMID: 24626533
  • Anderson RM, May RM. Infectious diseases of humans. 1st ed. Oxford, Oxford University Press; 1991
  • Kretzschmar M, Teunis PFM, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 2010; 7:e1000291; http://dx.doi.org/10.1371/journal.pmed.1000291; PMID: 20585374
  • WHO. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85:385 - 400; PMID: 20939150
  • Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ 2005; 172:509 - 15; http://dx.doi.org/10.1503/cmaj.1040766; PMID: 15710944
  • Donoso A, Arriagada D, Cruces P, Díaz F. Coqueluche grave: Estado del arte. Rev Chilena Infectol 2012; 29:290 - 306; http://dx.doi.org/10.4067/S0716-10182012000300007; PMID: 23096468
  • Spector TB, Maziarz EK. Pertussis. Med Clin North Am 2013; 97:537 - 52, ix; http://dx.doi.org/10.1016/j.mcna.2013.02.004; PMID: 23809713
  • Clark TA. Responding to pertussis. J Pediatr 2012; 161:980 - 2; http://dx.doi.org/10.1016/j.jpeds.2012.07.014; PMID: 22906510
  • Fedele G, Bianco M, Ausiello CM. The virulence factors of Bordetella pertussis: talented modulators of host immune response. Arch Immunol Ther Exp (Warsz) 2013; 61:445 - 57; http://dx.doi.org/10.1007/s00005-013-0242-1; PMID: 23955529
  • Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014; 209:978 - 81; http://dx.doi.org/10.1093/infdis/jiu001; PMID: 24626532
  • Higgs R, Higgins SC, Ross PJ, Mills KHG. Immunity to the respiratory pathogen Bordetella pertussis.. Mucosal Immunol 2012; 5:485 - 500; http://dx.doi.org/10.1038/mi.2012.54; PMID: 22718262
  • Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013; 9:e1003264; http://dx.doi.org/10.1371/journal.ppat.1003264; PMID: 23592988
  • Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, de Greeff SC, Diavatopoulos D, Teunis P, Nagelkerke N, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009; 15:1206 - 13; http://dx.doi.org/10.3201/eid1508.081511; PMID: 19751581
  • Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 2013; 368:583 - 4; http://dx.doi.org/10.1056/NEJMc1209369; PMID: 23388024
  • de Gouw D, Hermans PWM, Bootsma HJ, Zomer A, Heuvelman K, Diavatopoulos DA, Mooi FR. Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally. PLoS One 2014; 9:e84523; http://dx.doi.org/10.1371/journal.pone.0084523; PMID: 24416242
  • Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, McIntyre P, Marshall H, Guiso N, Keil AD, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis 2014; 20:626 - 33; http://dx.doi.org/10.3201/eid2004.131478; PMID: 24655754
  • WHO .Immunization, surveillance assessment and monitoring. Pertussis. 2012 global figures; www.who.int/immunization_monitoring/diseases/pertussis last update 23 July 2013 (Last access April 2014)
  • Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new?. Trends Microbiol 2012; 20:211 - 3; http://dx.doi.org/10.1016/j.tim.2012.03.003; PMID: 22494804
  • Centers for Disease Control and Prevention (CDC). 2012 final pertussis surveillance report; www.cdc.gov/pertussis/downloads/pertuss-surv-report-2012.pdf October 18, 2013 (last access April 2014)
  • Centers for Disease Control and Prevention (CDC).. Pertussis (whooping cough). Surveillance & reports. Trends; www.cdc.gov/pertussis/surv-reporting.html March 19, 2014 (last access April 2014)
  • Centers for Disease Control and Prevention (CDC). Pertussis epidemic--Washington, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:517 - 22; PMID: 22810264
  • Centers for Disease Control and Prevention (CDC).. Pertussis outbreak in an Amish community — Kent County, Delaware, September 2004–February 2005 MMWR. 2006;55(30):817-21
  • Centers for Disease Control and Prevention (CDC). Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007. MMWR Morb Mortal Wkly Rep 2008; 57:796 - 9; PMID: 18650787
  • Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012; 308:2126 - 32; http://dx.doi.org/10.1001/jama.2012.14939; PMID: 23188029
  • EUVAC.NET. Pertussis surveillance report 2003-2007. www.euvac.net 2009, (last access April 2014)
  • EUVAC.NET. Pertussis surveillance report 2010; ecdc.europa.eu/en/publications/Publications/pertussis_report_2010_euvacnet.pdf, issued 5 August 2011 (Last access April 2014)
  • Giammanco A, Chiarini A, Maple PAC, Andrews N, Pebody R, Gay N, Olander RM, Fivet-Groyne F, Baron S, Tischer A, et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 2003; 22:112 - 20; http://dx.doi.org/10.1016/S0264-410X(03)00514-0; PMID: 14604578
  • Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005; 133:159 - 71; http://dx.doi.org/10.1017/S0950268804003012; PMID: 15724723
  • Rota MC, D’Ancona F, Massari M, Mandolini D, Giammanco A, Carbonari P, Salmaso S, Ciofi degli Atti ML. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy. Vaccine 2005; 23:5299 - 305; http://dx.doi.org/10.1016/j.vaccine.2005.07.061; PMID: 16112254
  • ISS. Gruppo di Lavoro ICONA. Indagine 2008: indagine di copertura vaccinale nazionale nei bambini e negli adolescenti. Rapporti ISTISAN 2009, 09/29
  • Gabutti G, Bergamini M, Bonanni P, Guido M, Fenoglio D, Giammanco A, Sindoni L, Zotti C, Boddi V, Bamfi F, et al, Collaborative Group for the Study of Pertussis. Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy. Epidemiol Infect 2008; 136:1576 - 84; PMID: 18198000
  • Gabutti G, Rota MC, Bonato B, Pirani R, Turlà G, Cucchi A, Cavallaro A. Hospitalizations for pertussis in Italy, 1999-2009: analysis of the hospital discharge database. [Erratum appears in Eur J Pediatr. 2013; 172: 1425] Eur J Pediatr 2012; 171:1651 - 5; http://dx.doi.org/10.1007/s00431-012-1791-8; PMID: 22790868
  • Poland GA. Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations?. Vaccine 2012; 30:6957 - 9; http://dx.doi.org/10.1016/j.vaccine.2012.09.084; PMID: 23141958
  • Ridda I, Yin JK, King C, Raina MacIntyre C, McIntyre P. The importance of pertussis in older adults: a growing case for reviewing vaccination strategy in the elderly. Vaccine 2012; 30:6745 - 52; PMID: 22981762
  • Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013; 13:151; http://dx.doi.org/10.1186/1471-2334-13-151; PMID: 23530907
  • van der Maas NAT, Mooi FR, de Greeff SC, Berbers GAM, Spaendonck MA, de Melker HE. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?. Vaccine 2013; 31:4541 - 7; http://dx.doi.org/10.1016/j.vaccine.2013.07.060; PMID: 23933365
  • Frumkin K. Pertussis and persistent cough: practical, clinical and epidemiologic issues. J Emerg Med 2013; 44:889 - 95; http://dx.doi.org/10.1016/j.jemermed.2012.09.037; PMID: 23287746
  • Guiso N, Wirsing von König CH, Forsyth K, Tan T, Plotkin SA. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine 2011; 29:1115 - 21; http://dx.doi.org/10.1016/j.vaccine.2010.12.010; PMID: 21168525
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095 - 128; http://dx.doi.org/10.1016/S0140-6736(12)61728-0; PMID: 23245604
  • Marzouqi I, Richmond P, Fry S, Wetherall J, Mukkur T. Development of improved vaccines against whooping cough: current status. Hum Vaccin 2010; 6:543 - 53; http://dx.doi.org/10.4161/hv.6.7.11413; PMID: 20448470
  • Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1996; 174:Suppl 3 S259 - 63; http://dx.doi.org/10.1093/infdis/174.Supplement_3.S259; PMID: 8896526
  • Dias WO, van der Ark AAJ, Sakauchi MA, Kubrusly FS, Prestes AFRO, Borges MM, Furuyama N, Horton DS, Quintilio W, Antoniazi M, et al. An improved whole cell pertussis vaccine with reduced content of endotoxin. Hum Vaccin Immunother 2013; 9:339 - 48; http://dx.doi.org/10.4161/hv.22847; PMID: 23291935
  • Guiso N. How to fight pertussis?. Ther Adv Vaccines 2013; 1:59 - 66; http://dx.doi.org/10.1177/2051013613481348; PMID: 24757515
  • WHO. Improvements in the control of whooping cough. WER 1995; 35:255 - 6
  • Bar-On ES, Goldberg E, Hellmann S, Leibovici L. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Cochrane Database Syst Rev 2012; 4:CD005530; http://dx.doi.org/10.1002/14651858:CD005530.pub3; PMID: 22513932
  • Ray P, Hayward J, Michelson D, Lewis E, Schwalbe J, Black S, Shinefield H, Marcy M, Huff K, Ward J, et al, Vaccine Safety Datalink Group. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J 2006; 25:768 - 73; http://dx.doi.org/10.1097/01.inf.0000234067.84848.e1; PMID: 16940831
  • Cherry JD. Pertussis: the trials and tribulations of old and new pertussis vaccines. Vaccine 1992; 10:1033 - 8; http://dx.doi.org/10.1016/0264-410X(92)90113-X; PMID: 1471425
  • Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.. Vaccine 1998; 16:1907 - 16; http://dx.doi.org/10.1016/S0264-410X(98)00227-8; PMID: 9796042
  • Olin P, Hallander HO, Gustafsson L, Reizenstein E, Storsaeter J. How to make sense of pertussis immunogenicity data. Clin Infect Dis 2001; 33:Suppl 4 S288 - 91; http://dx.doi.org/10.1086/322564; PMID: 11709761
  • Mills KHG. Immunity to Bordetella pertussis.. Microbes Infect 2001; 3:655 - 77; http://dx.doi.org/10.1016/S1286-4579(01)01421-6; PMID: 11445452
  • Storsaeter J, Olin P. Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance. Vaccine 1992; 10:142 - 4; http://dx.doi.org/10.1016/0264-410X(92)90002-2; PMID: 1557928
  • Rota MC, Ausiello CM, D’Amelio R, Cassone A, Giammanco A, Molica C, Lande R, Greco D, Salmaso S. Prevalence of markers of exposure to Bordetella pertussis among Italian young adults. Clin Infect Dis 1998; 26:297 - 302; http://dx.doi.org/10.1086/516293; PMID: 9502445
  • Tran Minh NN, He Q, Edelman K, Olander RM, Viljanen MK, Arvilommi H, Mertsola J. Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children. Pediatr Infect Dis J 1999; 18:366 - 70; http://dx.doi.org/10.1097/00006454-199904000-00012; PMID: 10223692
  • Rieber N, Graf A, Hartl D, Urschel S, Belohradsky BH, Liese J. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response. PLoS One 2011; 6:e17271; http://dx.doi.org/10.1371/journal.pone.0017271; PMID: 21408149
  • Bernstein HH, Rothstein EP, Pichichero ME, Green JL, Reisinger KS, Blatter MM, Halpern J, Arbeter AM, Bernstein DI, Smith V, et al. Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States. Vaccine 1995; 13:1631 - 5; http://dx.doi.org/10.1016/0264-410X(95)00137-P; PMID: 8719512
  • Chang S, O’Connor PM, Slade BA, Woo EJUS. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007. Vaccine 2013; 31:1447 - 52; http://dx.doi.org/10.1016/j.vaccine.2012.10.097; PMID: 23142308
  • Taranger J, Trollfors B, Bergfors E, Knutsson N, Sundh V, Lagergård T, Lind-Brandberg L, Zackrisson G, White J, Cicirello H, et al. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis 2001; 33:1004 - 10; http://dx.doi.org/10.1086/322639; PMID: 11528572
  • Hallander HO, Gustafsson L. Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience. Expert Rev Vaccines 2009; 8:1303 - 7; http://dx.doi.org/10.1586/erv.09.88; PMID: 19803750
  • Trollfors B, Dotevall L, Sundh V, Welinder-Olsson C. Pertussis after end of a mass vaccination project--end of the “vaccination honey-moon”. Vaccine 2011; 29:2444 - 50; http://dx.doi.org/10.1016/j.vaccine.2011.01.021; PMID: 21292010
  • Hviid A, Stellfeld M, Andersen PH, Wohlfahrt J, Melbye M. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark. Vaccine 2004; 22:3530 - 4; http://dx.doi.org/10.1016/j.vaccine.2004.03.046; PMID: 15315832
  • Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 2013; 31:5178 - 91; http://dx.doi.org/10.1016/j.vaccine.2013.08.034; PMID: 23994021
  • Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Pertussis Investigation Team. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005; 116:e285 - 94; http://dx.doi.org/10.1542/peds.2004-2759; PMID: 16061582
  • Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013; 131:e1047 - 52; http://dx.doi.org/10.1542/peds.2012-1928; PMID: 23478868
  • Rendi-Wagner P, Kundi M, Mikolasek A, Vécsei A, Frühwirth M, Kollaritsch H. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine. Vaccine 2006; 24:5960 - 5; http://dx.doi.org/10.1016/j.vaccine.2006.05.011; PMID: 16757063
  • van der Maas NAT, Mooi FR, de Greeff SC, Berbers GAM, Spaendonck MA, de Melker HE. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?. Vaccine 2013; 31:4541 - 7; http://dx.doi.org/10.1016/j.vaccine.2013.07.060; PMID: 23933365
  • Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein NP. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013; 347:f4249; http://dx.doi.org/10.1136/bmj.f4249; PMID: 23873919
  • Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013; 131:e1716 - 22; http://dx.doi.org/10.1542/peds.2012-3836; PMID: 23690518
  • Gabutti G, Trucchi C, Conversano M, Zivelonghi G, Zoppi G. Booster vaccination: the role of reduced antigen content vaccines as a preschool booster. Biomed Res Int 2014; 2014:541319; http://dx.doi.org/10.1155/2014/541319; PMID: 24678509
  • Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Vaccine 2012; 30:5179 - 90; http://dx.doi.org/10.1016/j.vaccine.2012.06.005; PMID: 22709953
  • Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24:Suppl S58 - 61; http://dx.doi.org/10.1097/01.inf.0000160914.59160.41; PMID: 15876927
  • Lavine JS, King AA, Bjørnstad ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci U S A 2011; 108:7259 - 64; http://dx.doi.org/10.1073/pnas.1014394108; PMID: 21422281
  • Arinaminpathy N, Lavine JS, Grenfell BT. Self-boosting vaccines and their implications for herd immunity. Proc Natl Acad Sci U S A 2012; 109:20154 - 9; http://dx.doi.org/10.1073/pnas.1209683109; PMID: 23169630
  • Campins M, Moreno-Pérez D, Gil-de Miguel A, González-Romo F, Moraga-Llop FA, Arístegui-Fernández J, Goncé-Mellgren A, Bayas JM, Salleras-Sanmartí L. Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina. Enferm Infecc Microbiol Clin 2013; 31:240 - 53; http://dx.doi.org/10.1016/j.eimc.2012.12.011; PMID: 23411362
  • Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013; 31:618 - 25; http://dx.doi.org/10.1016/j.vaccine.2012.11.052; PMID: 23200883
  • McGuiness CB, Hill J, Fonseca E, Hess G, Hitchcock W, Krishnarajah G. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Infect Dis 2013; 13:32; http://dx.doi.org/10.1186/1471-2334-13-32; PMID: 23343438
  • Rønn PF, Dalby T, Simonsen J, Jørgensen CS, Linneberg A, Krogfelt KA. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark. Epidemiol Infect 2014; 142:729 - 37; http://dx.doi.org/10.1017/S0950268813002446; PMID: 24103353
  • Gonfiantini MV, Villani A, Gesualdo F, Pandolfi E, Agricola E, Bozzola E, Arigliani R, Tozzi AE. Attitude of Italian physicians toward pertussis diagnosis. Hum Vaccin Immunother 2013; 9:1485 - 8; http://dx.doi.org/10.4161/hv.24734; PMID: 23732898
  • Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74; http://dx.doi.org/10.1371/journal.pmed.0050074; PMID: 18366252
  • WHO Publication. Pertussis vaccines: WHO position paper--recommendations. Vaccine 2011; 29:2355 - 6; http://dx.doi.org/10.1016/j.vaccine.2010.11.059; PMID: 21129396
  • ECDC. ECDC guidance: Scientific panel on childhood immunization schedule: Diphtheria-tetanus-pertussis (DTP) vaccination. Stockholm, 2009; http://www.ecdc.europa.eu/en/publications/Publications/0911_GUI_ScientificPanel_on_Childhood_Immunisation_DTP.pdf
  • Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE, EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005; 24:761 - 5; http://dx.doi.org/10.1097/01.inf.0000177282.53500.77; PMID: 16148840
  • Campbell H, Amirthalingam G, Andrews N, Fry NK, George RC, Harrison TG, Miller E. Accelerating control of pertussis in England and Wales. Emerg Infect Dis 2012; 18:38 - 47; http://dx.doi.org/10.3201/eid1801.110784; PMID: 22260989
  • Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child 2013; 98:552 - 5; http://dx.doi.org/10.1136/archdischild-2012-302968; PMID: 23698594
  • Shinall MC Jr., Peters TR, Zhu Y, Chen Q, Poehling KA. Potential impact of acceleration of the pertussis vaccine primary series for infants. Pediatrics 2008; 122:1021 - 6; http://dx.doi.org/10.1542/peds.2007-3025; PMID: 18977982
  • Foxwell AR, McIntyre P, Quinn H, Roper K, Clements MS. Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in australia. Pediatr Infect Dis J 2011; 30:161 - 3; http://dx.doi.org/10.1097/INF.0b013e3181f43906; PMID: 20811313
  • de Greeff SC, Mooi FR, Schellekens JF, de Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 2008; 27:218 - 23; http://dx.doi.org/10.1097/INF.0b013e318161a2b9; PMID: 18277916
  • Gustafsson L, Hessel L, Storsaeter J, Olin P. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics 2006; 118:978 - 84; http://dx.doi.org/10.1542/peds.2005-2746; PMID: 16950988
  • EUVAC-NET. Pertussis surveillance. Final report; http://ecdc.europa.eu/en/publications/Publications/pertussis_report_1998_2002.pdf (Last access April 2014)
  • Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, Oppermann H, Wirsing von König CH, Reiter S. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009; 9:22; http://dx.doi.org/10.1186/1471-2334-9-22; PMID: 19243604
  • Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11:557 - 70; http://dx.doi.org/10.1016/S1473-3099(11)70007-X; PMID: 21600850
  • Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, Rebmann CA, Gabel J, Schauer SL, Lett SM. Infant pertussis: who was the source?. Pediatr Infect Dis J 2004; 23:985 - 9; http://dx.doi.org/10.1097/01.inf.0000145263.37198.2b; PMID: 15545851
  • Centers for Disease Control and Prevention (CDC). Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007. MMWR Morb Mortal Wkly Rep 2008; 57:796 - 9; PMID: 18650787
  • Wong CA, Taylor JA, Wright JA, Opel DJ, Katzenellenbogen RA. Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health 2013; 53:492 - 7; http://dx.doi.org/10.1016/j.jadohealth.2013.05.009; PMID: 23809613
  • ECDC. Vaccine schedule; http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx (Last access April 2014)
  • Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, et al, Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293 - 9; http://dx.doi.org/10.1097/01.inf.0000258699.64164.6d; PMID: 17414390
  • McGuiness CB, Hill J, Fonseca E, Hess G, Hitchcock W, Krishnarajah G. The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study. BMC Infect Dis 2013; 13:32; http://dx.doi.org/10.1186/1471-2334-13-32; PMID: 23343438
  • Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule United States 2013; http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-schedule.pdf
  • de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 2010; 50:1339 - 45; http://dx.doi.org/10.1086/652281; PMID: 20370464
  • Halperin BA, Morris A, Mackinnon-Cameron D, Mutch J, Langley JM, McNeil SA, Macdougall D, Halperin SA. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis 2011; 53:885 - 92; http://dx.doi.org/10.1093/cid/cir538; PMID: 21946190
  • Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012; 54:78 - 84; http://dx.doi.org/10.1093/cid/cir765; PMID: 22075790
  • Frère J, De Wals P, Ovetchkine P, Coïc L, Audibert F, Tapiero B. Evaluation of several approaches to immunize parents of neonates against B. pertussis. Vaccine 2013; 31:6087 - 91; http://dx.doi.org/10.1016/j.vaccine.2013.09.043; PMID: 24099874
  • Skowronski DM, Janjua NZ, Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012; 54:318 - 27; http://dx.doi.org/10.1093/cid/cir836; PMID: 22156850
  • Tozzi AE, Vitali Rosati G, Ciarrocchi G, Ferrera G, Gabutti G, Giuffrida S, et al. Riduzione del rischio di pertosse nel neonato mediante vaccinazione: la strategia cocoon in Italia. RIAP 2012; 2:S2 1 - 10
  • Conyn MAE, van der Maas NAT, Mooi FM. RIVM Letter report 215121002/2012. Control of whooping cough in the Netherlands. Optimisation of the vaccination policy. RIVM, 2012
  • Belloni C, De Silvestri A, Tinelli C, Avanzini MA, Marconi M, Strano F, Rondini G, Chirico G. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003; 111:1042 - 5; http://dx.doi.org/10.1542/peds.111.5.1042; PMID: 12728086
  • Halasa NB, O’Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008; 153:327 - 32; http://dx.doi.org/10.1016/j.jpeds.2008.03.011; PMID: 18534242
  • Knuf M, Schmitt HJ, Wolter J, Schuerman L, Jacquet JM, Kieninger D, Siegrist CA, Zepp F. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008; 152:655 - 60, e1; http://dx.doi.org/10.1016/j.jpeds.2007.09.034; PMID: 18410769
  • Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010; 29:209 - 15; http://dx.doi.org/10.1097/INF.0b013e3181bc98d5; PMID: 20009964
  • White OJ, Rowe J, Richmond P, Marshall H, McIntyre P, Wood N, Holt PG. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine 2010; 28:2648 - 52; http://dx.doi.org/10.1016/j.vaccine.2010.01.010; PMID: 20096390
  • Leuridan E, Hens N, Peeters N, de Witte L, Van der Meeren O, Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011; 30:608 - 10; http://dx.doi.org/10.1097/INF.0b013e3182093814; PMID: 21206396
  • Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013; 56:539 - 44; http://dx.doi.org/10.1093/cid/cis923; PMID: 23097585
  • Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003; 21:3406 - 12; http://dx.doi.org/10.1016/S0264-410X(03)00342-6; PMID: 12850349
  • Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207:e1 - 7, e7; http://dx.doi.org/10.1016/j.ajog.2012.05.006; PMID: 22727350
  • Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013; 62:131 - 5; PMID: 23425962
  • Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011; 204:e1 - 5, e5; http://dx.doi.org/10.1016/j.ajog.2010.11.024; PMID: 21272845
  • Kaltsas A, Sepkowitz K. Vaccinations for healthcare personnel: update on influenza, hepatitis B, and pertussis. Curr Opin Infect Dis 2013; 26:366 - 77; PMID: 23806899
  • Sandora TJ, Gidengil CA, Lee GM. Pertussis vaccination for health care workers. Clin Microbiol Rev 2008; 21:426 - 34; http://dx.doi.org/10.1128/CMR.00003-08; PMID: 18625679
  • Elumogo TN, Booth D, Enoch DA, Kuppuswamy A, Tremlett C, Williams CJ, Shankar A, Morter S. Bordetella pertussis in a neonatal intensive care unit: identification of the mother as the likely source. J Hosp Infect 2012; 82:133 - 5; http://dx.doi.org/10.1016/j.jhin.2012.07.012; PMID: 22940441
  • Cohen S, Black A, Ross A, Mandel ED. Updated treatment and prevention guidelines for pertussis. JAAPA 2014; 27:19 - 25, quiz 26; http://dx.doi.org/10.1097/01.JAA.0000438528.61644.91; PMID: 24321856

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.